ExamWorks Group PT Raised to $37.00 (EXAM)
Analysts at Credit Suisse raised their price target on shares of ExamWorks Group (NASDAQ:EXAM) from $32.00 to $37.00 in a research report issued to clients and investors on Wednesday, AnalystRatings.Net reports. Credit Suisse’s price target indicates a potential upside of 20.92% from the company’s current price.
ExamWorks Group (NASDAQ:EXAM) traded up 17.19% on Wednesday, hitting $35.86. The stock had a trading volume of 2,513,612 shares. ExamWorks Group has a 1-year low of $13.82 and a 1-year high of $32.48. The stock’s 50-day moving average is $30.55 and its 200-day moving average is $27.52. The company’s market cap is $1.306 billion.
ExamWorks Group (NASDAQ:EXAM) last released its earnings data on Tuesday, February 25th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by $0.02. The company had revenue of $158.80 million for the quarter, compared to the consensus estimate of $151.51 million. On average, analysts predict that ExamWorks Group will post $0.08 earnings per share for the current fiscal year.
Separately, analysts at Zacks downgraded shares of ExamWorks Group from an “outperform” rating to a “neutral” rating in a research note on Tuesday, December 3rd. They now have a $31.90 price target on the stock.
ExamWorks Group, Inc (NASDAQ:EXAM) is a provider of independent medical examinations (IMEs), peer and bill reviews, and related services, referred to as IME services or the IME industry.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.